Faculty Opinions recommendation of The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment.

2006 ◽  
Author(s):  
Diego Kyburz
Keyword(s):  
Rheumatoid Arthritis ◽  
Clinical Trial ◽  
Combination Therapy ◽  
Double Blind ◽  
Double Blind Clinical Trial ◽  
Methotrexate Treatment

Effects of Probiotic Supplementation on Oxidative Stress Indices in Women with Rheumatoid Arthritis: A Randomized Double-Blind Clinical Trial

2015 ◽  
Vol 35 (4) ◽  
pp. 291-299 ◽  
Author(s):  
Elnaz Vaghef-Mehrabany ◽  
Aziz Homayouni-Rad ◽  
Beitullah Alipour ◽  
Sakineh-Khatoun Sharif ◽  
Leila Vaghef-Mehrabany ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Oxidative Stress ◽  
Clinical Trial ◽  
Probiotic Supplementation ◽  
Double Blind ◽  
Stress Indices ◽  
Double Blind Clinical Trial

A Long Term Double-Blind Clinical Trial of Ibuprofen and Indomethacin in Rheumatoid Arthritis

1975 ◽  
Vol 3 (3) ◽  
pp. 158-171 ◽  
Author(s):  
G L Royer ◽  
T E Moxley ◽  
M S Hearron ◽  
A Miyara ◽  
B M Shenker
Keyword(s):  
Rheumatoid Arthritis ◽  
Clinical Trial ◽  
Side Effects ◽  
Double Blind ◽  
Double Blind Clinical Trial

Two-hundred and eighteen individuals with rheumatoid arthritis were randomly assigned to six months treatment with ibuprofen (900-1800 mg/day) or indomethacin (75-150 mg/day). The drugs were equally effective in the treatment of rheumatoid arthritis while the incidence of indomethacin side-effects was 1·5 times greater than the incidence of ibuprofen side-effects.

Sign in / Sign up

Export Citation Format

Share Document